• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Practice Fusion Partners with Wolters Kluwer Health to Integrate Medi-Span Drug Database

by HITC Staff 03/25/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Practice Fusion

Practice Fusion, a cloud-based EHR for physicians and patients, announced that it is partnering with Wolters Kluwer Health to integrate the Medi-Span core drug database impacting more than 4 million e-prescriptions per month sent by Practice Fusion’s 112,00 active medical professionals.. The medical professionals that use the Practice Fusion EHR will now have access to the latest medication information and recommended dosages when they e-prescribe medications to patients.  

Integration Details

The integration of the Medi-Span database into the Practice Fusion EHR will help ensure that providers using the Practice Fusion EHR have the latest information on therapeutics, including newly approved medications. Medi-Span content also provides pre-configured prescription medication orders for more than 5,000 of the most common prescriptions, enabling e-prescribing providers to more easily enter prescriptions, while helping to reduce medication prescription errors.

Providers save time by getting relevant and up-to-date prescription medication information directly through the Practice Fusion EHR, and patients can get the right medication they need. Clinical decision support interventions through Medi-Span drug-drug and drug-allergy checks offer real-time alerts to providers about possible drug interactions that could otherwise affect their patients’ health.

rp_ryanhoward.jpg
Ryan Howard

“Patients have over 2 million adverse reactions each year leading to over 2,000 deaths from drug interactions. By integrating with Medi-Span, we can help ensure that doctors not only have the last approved medications and their side effects, but also that they are quickly alerted while they are writing a prescription about any potential adverse reactions that may harm their patients,” said Ryan Howard, founder and CEO, Practice Fusion in a statement. “This service is live and impacting more than four million prescriptions written by doctors using Practice Fusion’s EHR platform each month.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |